105 related articles for article (PubMed ID: 3236647)
1. [Effect of essential phospholipids on the lipid spectrum of blood plasma and the aggregative capacity of thrombocytes in patients with ischemic heart disease].
Botolova EN; Solov'ev VV; Ozerova IN; Polesskiĭ VA; Pomykalov SV
Kardiologiia; 1988 Sep; 28(9):57-61. PubMed ID: 3236647
[TBL] [Abstract][Full Text] [Related]
2. [Plasma lipoprotein levels and functional status of thrombocytes in patients with ischemic heart disease during treatment with essential phospholipids].
Belousova SS; Bogoslovskaia SI; Silagina LM
Kardiologiia; 1985 Sep; 25(9):112-5. PubMed ID: 4079219
[TBL] [Abstract][Full Text] [Related]
3. Evidence of combined therapy of dyslipoproteinemia by HMG-CoA reductase inhibitors and "essential" phospholipids.
Gurevich VS; Bondarenko BB; Mikhailova IA; Kasennova NI; Popov YuG ; Astashkina ; Le Van Thach TD
Clin Ter; 1993 Apr; 142(4):329-34. PubMed ID: 8330475
[TBL] [Abstract][Full Text] [Related]
4. [Dynamics of blood lipids and indicators of lipid peroxidation and energy metabolism after administration of Essentiale to patients with ischemic heart disease].
Serkova VK
Klin Med (Mosk); 1986 Jul; 64(7):91-5. PubMed ID: 3762044
[No Abstract] [Full Text] [Related]
5. [Effect of verapamil on the functional status of thrombocytes in patients with ischemic heart disease].
Belousov IuB; Azizova OA; Razumov VB; Gutkin AB; Borin ML
Kardiologiia; 1989 Feb; 29(2):42-5. PubMed ID: 2724766
[TBL] [Abstract][Full Text] [Related]
6. [Aggregative function of thrombocytes and the status of the anticoagulation system of the blood in patients with ischemic heart disease during treatment with nitroderm].
Zadionchenko VS; Kamenker ES; Smirnov VK; Akhmedova FD; Vasil'ev KA
Klin Med (Mosk); 1989 Mar; 67(3):72-3. PubMed ID: 2501553
[No Abstract] [Full Text] [Related]
7. [Effect of lipostabil on cholesterol levels in atherosclerotic plaques of the human aorta and the aggregative capacity of thrombocytes (in vitro study)].
Khashimov KhA; Okur F; Orekhov AN; Kurdanov KhA; Tertov V
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):95-8. PubMed ID: 3401347
[TBL] [Abstract][Full Text] [Related]
8. [The influence of ezetimibe and simvaststin on platelet aggregation and protein c system in patients with coronary heart disease and hypercholesterolemia].
Vashchenko VI; Kozobova AI; Filippov AE; Chechetkin AV; Popova NN; Vil'ianinov VN; Vashchenko TN
Klin Med (Mosk); 2012; 90(3):66-8. PubMed ID: 22690571
[TBL] [Abstract][Full Text] [Related]
9. [The role of thrombocytes and thrombocyte aggregation inhibitors in coronary disease].
Schlimmer P
ZFA (Stuttgart); 1980 Sep; 56(26):1621-4. PubMed ID: 7456654
[No Abstract] [Full Text] [Related]
10. [Plasma and platelet lipids in patients with newly diagnosed angina and chronic heart disease].
Suvorova LA; Korolev AB; Shalaev SV; Perova NV
Vopr Med Khim; 1990; 36(4):24-8. PubMed ID: 2238527
[TBL] [Abstract][Full Text] [Related]
11. [The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise].
Kovalenko VM; Shunkova EI; Gol'dberg GA; Karagaeva LG; Shlafer ID; Epifantseva NN
Kardiologiia; 1991 Sep; 31(9):42-4. PubMed ID: 1753613
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of dilzem treatment of patients with ischemic heart disease].
Zharov EI; Styrova TK; Martynov AI; Barinov VG; Makarovskiĭ VV; Vertkin AL; Sedov VP; Galichenko IV
Kardiologiia; 1990 Dec; 30(12):30-3. PubMed ID: 2097392
[TBL] [Abstract][Full Text] [Related]
13. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis].
Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G
Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297
[No Abstract] [Full Text] [Related]
14. [Characteristics of nicardipine treatment of patients with ischemic heart disease].
Zharov EI; Makarovskiĭ VV; Styrova TK; Galichenko IV; Barinov VG; Martynov AI; Vertkin AL
Kardiologiia; 1991 Mar; 31(3):16-8. PubMed ID: 1875588
[TBL] [Abstract][Full Text] [Related]
15. [Effect of polyunsaturated fatty acids on the functional properties of the thrombocytes and on lipid peroxidation in ischemic heart disease patients].
Dudaev VA; Abbud A; Ivanov AS
Kardiologiia; 1987 Jun; 27(6):79-83. PubMed ID: 3626287
[TBL] [Abstract][Full Text] [Related]
16. [The lipid composition and aggregating capacity of thrombocytes in hyper- and hypothyroidism].
Saipov TD; Aripov DA; Khashimova RM; Abduzhamilov AA; Saatov TS
Probl Endokrinol (Mosk); 1989; 35(5):47-50. PubMed ID: 2587526
[TBL] [Abstract][Full Text] [Related]
17. [Platelet aggregation in patients with coronary disease treated with nifedipine].
Tkaczewski W; Goch JH; Kruszyński G; Ryniec A
Pol Tyg Lek; 1990 Mar 5-12; 45(10-11):219-21. PubMed ID: 2216944
[TBL] [Abstract][Full Text] [Related]
18. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
19. [Effect of diltiazem on the functional activity of erythrocytes and thrombocytes in patients with ischemic heart disease].
Razumov VB; Gutkin AB; Leonova MV; Khudiakova ND
Kardiologiia; 1989 Oct; 29(10):54-6. PubMed ID: 2615159
[TBL] [Abstract][Full Text] [Related]
20. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
